CognoSpeak: AI Assists Doctors in Detecting Early Signs of Dementia

2023-07-04

A new artificial intelligence tool developed by university researchers helps doctors assess early signs of diseases more quickly and effectively


Researchers at the University of Sheffield have been developing CognoSpeak, a tool that helps identify early signs of dementia and Alzheimer's disease. The system uses a virtual agent displayed on the screen to engage in conversation with patients.



During the conversation, the tool asks thought-provoking questions inspired by those used in outpatient consultations and conducts cognitive tests such as picture description and language fluency tests. It then uses artificial intelligence and speech technology to analyze language and speech patterns, looking for signs of memory impairment. This tool has the potential to revolutionize the healthcare field globally by aiding in the early detection of brain diseases.

Artificial Intelligence in Healthcare: Breaking Barriers with Algorithms

Artificial intelligence has proven to be crucial in global healthcare. In May 2023, scientists announced that artificial intelligence was used to discover a new antibiotic, abaucin, which showed effectiveness against superbugs considered a serious threat to humanity by the World Health Organization.

Other groundbreaking discoveries include Google's AlphaFold, which can predict protein structures, changing the way this type of science operates and making results faster and more effective in combating diseases.

CognoSpeak has been hailed for its immense potential in assessing patients with memory issues more quickly and effectively. Efficiency is key as early intervention is crucial. With a sharp increase in referrals over the past decade, it could lead to more people being examined faster, reducing delays.

Scientists at the Sheffield Institute for Translational Neuroscience (SITraN) have been searching for ways to detect dementia earlier and studying potential treatment methods to slow down the progression of currently incurable diseases.

CognoSpeak's system is presented as a "digital doctor" who can speak on the computer screen. According to the department's website, speech technology and machine learning are used to extract and classify different speech patterns indicating neurodegenerative dementia or functional memory impairment for diagnosis.

As a result, this tool serves as a low-cost, repeatable, non-invasive, and less stressful alternative to current cognitive assessment methods. It can even be conducted in the comfort of a patient's home, opening up possibilities for its future use globally.

It may also provide faster comfort, appropriate advice, and support to individuals with diseases such as Alzheimer's. The combination of clinical expertise and technology in this way has the potential to positively transform healthcare in the future.

As artificial intelligence is being discussed as part of providing much-needed mental health solutions, the application of this technology can reduce waiting times and improve patient outcomes.

Early testing of artificial intelligence by the university shows a 90% accuracy rate in predicting functional memory impairment or neurodegenerative dementia for clinical diagnosis. It has the potential to change screening for dementia and early signs of Alzheimer's by altering the interpretation of brain scans and using different memory tests.

Dr. Dan Blackburn from the Department of Neuroscience at the University of Sheffield said, "The CognoSpeak system can change the way dementia and other memory impairments are diagnosed by speeding up the assessment process."

"This will also save valuable time for clinicians and mean that those in need of specialist care can receive it as soon as possible."



Source: https://aimagazine.com/articles/cognospeak-ai-aids-doctors-in-spotting-early-dementia-signs

RECENT AI NEWS

RECENT AI TOOLS